Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 kinase beta 1 (p70S6K) is a serine/threonine kinase that plays crucial roles in cell growth, proliferation, and survival. It functions downstream of the PI3K/mTOR signaling pathway and is involved in regulating protein synthesis, cell cycle progression, and cellular motility. Dysregulation of p70S6K has been implicated in various pathological conditions, including cancer, metabolic disorders, fibrosis, and aging, making it an important therapeutic target and biomarker.
Inhibition of p70S6K activity, thereby reducing protein synthesis and cell growth.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal Protein S6 Kinase Beta 1 (p70S6K).